.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Scientists have identified a schizophrenia biomarker for cognition that may revolutionize treatment for the disorder. Currently, most medications focus on hallucinations but overlook cognitive deficits. This lack of treatment for executive dysfunction often prevents patients from integrating into society.
Researchers from Northwestern University analyzed the cerebrospinal fluid of over 100 participants. They found reduced levels of a protein called Cacna2d1 in patients with schizophrenia. This protein plays a vital role in maintaining the balance of brain circuits. When levels drop, circuits become overexcited, leading to cognitive symptoms like disorganized thinking.
To address this deficiency, the research team developed a synthetic version of the protein named SEAD1. During trials on mouse models, a single injection corrected abnormal brain activity. It also restored behavioral problems without significant side effects. Consequently, this approach offers hope for a targeted peptide therapy. Moreover, this discovery allows clinicians to identify a specific subgroup of patients likely to respond to the drug. Because of this, it moves psychiatry closer to the precision medicine models used in other chronic diseases.
The restoration of synaptic plasticity could benefit other disorders, including depression. Furthermore, researchers aim to develop a less invasive blood-based assay for easier monitoring. Although long-term effects are unknown, the initial results mark a significant step forward in neuroscience. In addition, the team is working to optimize the delivery of SEAD1 for human use.
Q1: What is the new biomarker identified for schizophrenia?
The biomarker is a freely circulating form of the brain protein called 'Cacna2d1,' which is found at reduced levels in patients with cognitive symptoms.
Q2: How does the SEAD1 drug work to treat symptoms?
SEAD1 is a synthetic peptide that mimics the Cacna2d1 protein. It helps recalibrate overexcited brain circuits and restore synaptic plasticity to improve cognitive function.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Northwestern University researchers identify the Cacna2d1 protein as a biomarker for cognitive symptoms of schizophrenia, leading to a new peptide drug targ...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
